Atlanta, GA
March 13-14, 2026

Two Days. One Mission. Transforming Precision Cancer Care.

Atlanta, GA
March 13-14, 2026

Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Atlanta

Advancing precision medicine across the Southeast
Atlanta stands at the crossroads of innovation and patient-centered cancer care. The Advancing Pathology Education and Advancing Precision Oncology regional program brings together leading experts from across the Southeast to explore how biomarker-driven diagnostics and targeted therapeutics are transforming oncology practice.

This free, CME-accredited meeting unites pathology and oncology professionals to strengthen collaboration across hospital systems and academic centers—ensuring that every patient benefits from the latest advances in precision medicine.

Agenda

Registration Coming Soon!

March 13, 2026
8:00 AM	Registration & Check-in
8:50 AM	Welcome and Introductions
9:00 AM	Breast Cancer: Biomarkers & Methodologies
9:30 AM	Breast Cancer
10:00 AM	Breakfast/Exhibits
10:30 AM	Non-CME Session
11:15 AM	Break/Exhibits
11:45 AM	Lung Cancer: Biomarkers and Methodologies
12:15 PM	Lung Cancer
12:45 PM	Gastrointestinal: Biomarkers & Methodologies
1:15 PM	Gastrointestinal Cancer
1:45 PM	Lunch/Exhibits
2:15 PM	Non-CME Session
2:45 PM	Break/Exhibits
3:15 PM	Digital Pathology
3:45 PM	Liquid Biopsy
4:15 PM	Closing Remarks

Learning Objectives

Integrate evidence-based advances from both pathology and oncology to enhance biomarker testing, diagnosis, and treatment planning for solid tumors and hematologic malignancies.
Apply multidisciplinary insights and new clinical data to improve therapeutic decision-making and patient outcomes across diverse practice settings.

Accreditation Information | TBD CE/CME Credits

Additional Information Coming Soon

March 14, 2026
8:00 AM	Registration & Check-in
8:25 AM	Welcome and Introductions
8:30 AM	Ovarian Cancer: Biomarkers & Methodologies
9:00 AM	Ovarian Cancer
9:30 AM	Breakfast/Exhibits
10:00 AM	Non-CME Session
10:45 AM	Break/Exhibits
11:15 AM	Hemapathology
11:45 PM	Myeloma
12:15 PM	Leukemia
12:45 PM	Lunch/Exhibits
1:15 PM	Non-CME Session
2:00 PM	Break/Exhibits
2:30 PM	Genitourinary: Biomarkers & Methodologies
3:00 PM	Genitourinary Cancer Bamidele A. Adesunloye, MD, MS, FACP, City of Hope
3:30 PM	Precision Oncology
4:00 PM	Closing Comments

Speakers

CHAIR
Debora Bruno, MD, MS
Medical Director, Clinical Research
Thoracic Medical Oncologist
City of Hope Cancer Center Atlanta
View Profile
Medical Director, Clinical Research
Thoracic Medical Oncologist
City of Hope Cancer Center Atlanta
Debora Bruno, M.D., M.S., is medical director of clinical research and a thoracic medical oncologist at City of Hope® Cancer Center Atlanta. A recognized expert in her field, Dr. Bruno treats lung cancer and mesothelioma, as well as thymoma and thymic carcinoma. In other duties, she oversees City of Hope Atlanta’s clinical trials program, which investigates and develops new treatment options for patients.
Originally from Brazil, Dr. Bruno earned her medical degree from the Federal University of Ceara School of Medicine in Fortaleza, Brazil, and her master’s degree in cancer biology from MD Anderson Cancer Center in Houston, Texas. She went on to complete her first internal medicine internship at Walter Cantidio University Hospital in Fortaleza, followed by a second at Philadelphia’s Albert Einstein Medical Center. She concluded her training at Thomas Jefferson University Hospital in Philadelphia, where she completed a hematology-oncology residency and a transfusion medicine residency.
Inspired by her physician father and her experiences working with patients during medical school, Dr. Bruno is dedicated to a compassionate and respectful approach to cancer care. In the clinic, she builds a strong connection with her patients both during and after their cancer journey and collaborates with their cancer care teams to craft comprehensive and effective treatment plans that treat each patient like a person, not a diagnosis.
A respected physician-scholar, Dr. Bruno has more than 100 publications, abstract presentations and book chapters to her name, oversees dozens of clinical trials and has been recognized with multiple awards. She’s active in several professional societies and serves as a member of the National Comprehensive Cancer Network’s Clinical Practice Guidelines in Oncology Committee, which determines standards of care for non-small cell lung cancer, malignant pleural mesothelioma and thymomas and thymic carcinomas.
Bamidele A. Adesunloye, MD, MS, FACP
Medical Oncologist
Chief, Medical Oncology
City of Hope Cancer Center Atlanta
View Profile
Medical Oncologist
Chief, Medical Oncology
City of Hope Cancer Center Atlanta
Dr. Adesunloye, is a board-certified medical oncologist and hematologist at City of Hope Atlanta. He works within a multidisciplinary team to evaluate and treat patients with a broad range of malignancies, with a clinical focus on genitourinary cancers, including prostate, bladder, and kidney cancer.
Dr. Adesunloye is dedicated to delivering patient-centered, personalized cancer care and partners closely with patients and their families to develop integrative treatment plans. He emphasizes education and shared decision-making, ensuring patients are well informed and actively engaged throughout their cancer journey.
He earned his medical degree from the University of Ilorin in Nigeria and completed an internal medicine residency at Morehouse School of Medicine, where he also obtained a Master of Science degree in clinical research. He subsequently completed a fellowship in hematology and medical oncology at the National Cancer Institute, National Institutes of Health. Dr. Adesunloye has practiced in diverse clinical and academic settings and has held academic appointments at Indiana University School of Medicine and Morehouse School of Medicine. He is an active member of several professional organizations, including the American Society of Clinical Oncology.